Full name
ASCLEPIOS SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
47.73.Z - Retail sale of pharmaceutical products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
47.74.Z - Retail sale of medical and orthopedic products
47.75.Z - Retail sale of cosmetics and toiletries
86.10.Z - Hospital activities
86.22.Z - Specialist medical practice
86.90.B - Healthcare
86.90.D - Healthcare
86.90.E - Healthcare
96.09.Z - Individual service activities
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale | -0 | -365,5 | ||
Gross profit (loss) | 0 | -0,1 | -0 | 73 |
EBITDA | 0,1 | -0 | -0 | 86,1 |
Short time liabilities | 0,8 | 0,8 | 1,2 | 59,4 |
Other operating costs | 0 | 1053,1 | ||
Equity capital | 0,1 | -0 | -0,1 | -70,4 |
Operating profit (EBIT) | 0 | -0,1 | -0 | 82,1 |
Assets | 0,9 | 0,7 | 1,1 | 59,7 |
Net profit (loss) | 0 | -0,1 | -0 | 70 |
Cash | 0,1 | 0 | 0,1 | 231,8 |
Liabilities and provisions for liabilities | 0,9 | 0,8 | 1,2 | 60,4 |
Net income from sale | 4,1 | 4,5 | 3,6 | -18,3 |
Working assets | 0,7 | 0,7 | 1,1 | 58,6 |
Other income costs | 0,1 | 4,6 | ||
Depreciation | 0 | 0 | 0 | -77,5 |
% | % | % | p.p. | |
Profitability of capital | 17,6 | 234,9 | 41,3 | -193,6 |
Equity capital to total assets | 7 | -6,7 | -7,2 | -0,5 |
Gross profit margin | 0,3 | -2,5 | -0,8 | 1,7 |
EBITDA Margin | 1,7 | -1,1 | -0,2 | 0,9 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 74 | 63 | 122 | 59 |
Current financial liquidity indicator | 0.7948295474052429 | 0.9370003342628479 | 0.9321190118789673 | 0 |
Net dept to EBITDA | 1.5056335926055908 | 0.8397480249404907 | -8.117030143737793 | -8,9 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane